PepsiCo Is Cutting Around 1,000 Jobs Across North America -- WSJ
Dow Jones2026/11/09 19:00By Laura Cooper
PepsiCo is eliminating roughly 1,000 jobs across its food and beverage division as it attempts to turn the company around.
PepsiCo North America Chief Executive Ram Krishnan on Monday said that the food and beverage company will make changes over the next week to streamline operations, according to a letter to employees viewed by The Wall Street Journal.
"We will simplify how we operate, better connect teams and strengthen the capabilities we need," Krishnan said in the letter. "The goal is to move faster, executive better and invest behind the opportunities that will drive our growth."
Last month PepsiCo cut its full-year earnings outlook and reported continued weakness in its North American business, especially in its storied beverage division.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
November 09, 2026 14:00 ET (19:00 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Crypto prices
More
